The Activity of Tissue Engineering Skin Substitutes
NCT02668042 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2016-01-29
Summary
The main purpose of this experiment was to evaluate the activity of tissue engineering skin substitutes safety and efficacy studies for the treatment of difficult to heal wounds
Conditions
- Difficult to Heal Wounds
Interventions
- BIOLOGICAL
-
liveness tissue skin
liveness tissue skin safety and effectiveness for the treatment of difficult to heal wounds
Sponsors & Collaborators
-
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
xiaobing Fu · Chinese PLA General Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 17 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn
NCT01562119 ·Status: UNKNOWN
-
A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE
NCT04925323 ·Status: UNKNOWN ·Phase: NA
-
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites
NCT04234750 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
NCT02145130 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect
NCT02980601 ·Status: TERMINATED ·Phase: NA
-
Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
NCT05882110 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration
NCT03406143 ·Status: UNKNOWN ·Phase: NA
-
Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
NCT01769144 ·Status: UNKNOWN ·Phase: NA
-
Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites
NCT03334656 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
One-step Application of Artificial Dermis
NCT05666830 ·Status: COMPLETED
-
Negative Pressure Wound Therapy for Skin Grafts
NCT02374528 ·Status: COMPLETED ·Phase: NA
-
Double-layer Artificial Dermal Repair Material Combined With Growth Factors is Used for Exposed Tendon Wounds
NCT05600166 ·Status: UNKNOWN
-
Treatment of Pressure Ulcers Using Biological Skin Substitutes
NCT06853210 ·Status: COMPLETED ·Phase: NA
-
Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh
NCT04344483 ·Status: COMPLETED ·Phase: NA
-
An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns
NCT01454310 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of a Transparent Silicone Membrane With Physical Microstructure for Second-degree Burn Wounds and Skin Graft Wounds
NCT06170008 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique
NCT02982096 ·Status: COMPLETED ·Phase: NA
-
The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes
NCT01884831 ·Status: UNKNOWN ·Phase: PHASE2
-
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442 ·Status: RECRUITING ·Phase: PHASE4
-
Autologous Adipose Stem Cell Assisted Skin Graft
NCT04532593 ·Status: UNKNOWN ·Phase: NA
-
Human Tissue Repository for Wound Care
NCT01432054 ·Status: WITHDRAWN
-
Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
NCT04483934 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reducing Side-effects of Autologous Skin Tissue Harvesting
NCT02234193 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Microscopic Skin Tissue Column Grafting Technique Using the Autologous Regeneration of Tissue System
NCT05324514 ·Status: UNKNOWN ·Phase: NA
-
Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision
NCT04538885 ·Status: UNKNOWN ·Phase: PHASE1